Unpacking CSRD: A Guide for Business
In this episode of Ibec Responds, we delve into the upcoming changes brought by the Corporate Sustainability Reporting Directive (CSRD) with expert insights from Ibec's Kara McGann, Dr Dorothy Maxwell and Dr Helen Kavanagh of Davy Horizons.
MORE WAYS TO LISTEN
DownloadIn this episode of Ibec Responds, we delve into the upcoming changes brought by the Corporate Sustainability Reporting Directive (CSRD) with expert insights from Kara McGann, Head of Skills and Social Policy at Ibec, and guest speakers Dr Dorothy Maxwell and Dr Helen Kavanagh of Davy Horizons.
As Ibec and Davy Horizons prepare to launch their new toolkit, Unpacking CSRD: A Guide for Business, the conversation explores the significant implications of these new regulations. Dr Maxwell and Dr Kavanagh discuss what businesses must do to remain compliant, how the scope of CSRD will affect both large and smaller entities, and the broader influence of sustainability on corporate reporting practices.
Explore the toolkit at www.ibec.ie/CSRD.
Listen / Previous Episodes
Ep. 93 / Ibec Responds
Q3 2025 Ibec Economic Outlook
In this episode, Gerard Brady discusses key findings from our latest Economic Outlook report with Hazel Ahern-Flynn and Mourad Mejdi.
Ep. 92 / Ibec Responds
Reaction: Government’s Action Plan on Competitiveness and Productivity
Gerard Brady and Fergal O’Brien give reaction and examine the detail of the Government's Action Plan.
Ep. 91 / Ibec Responds
Powering Innovation: NIBRT’s Role in Ireland’s Cell and Gene Therapy Future.
Sinead Keogh, Director of BioPharmaChem Ireland, is in conversation with Darrin Morrissey, CEO of NIBRT.
Ep. 90 / Ibec Responds
INSPIRE: Ireland’s Next Step in Biopharma Innovation
Dr Sinead Keogh, Director of BioPharmaChem Ireland and Ibec Head of Sectors, is joined by Jamie Guidera, interim COO at SSPC. Together, they explore the centre’s academic foundations, its powerful industry network, and how Ireland’s strategic positioning in a fast-moving global landscape of therapeutic discovery.